Eyenovia Inc. (NASDAQ: EYEN)
$1.16
+0.0900 ( +8.41% ) 1.3M
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
Market Data
Open
$1.16
Previous close
$1.07
Volume
1.3M
Market cap
$71.89M
Day range
$1.05 - $1.19
52 week range
$0.50 - $2.57
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Apr 08, 2024 |
4 | Insider transactions | 1 | Mar 28, 2024 |
4 | Insider transactions | 1 | Mar 20, 2024 |
8-k | 8K-related | 49 | Mar 19, 2024 |
10-k | Annual reports | 104 | Mar 18, 2024 |
4 | Insider transactions | 1 | Mar 11, 2024 |
4 | Insider transactions | 1 | Feb 14, 2024 |
4 | Insider transactions | 1 | Feb 14, 2024 |
4 | Insider transactions | 1 | Feb 14, 2024 |
8-k/a | 8K-related | 45 | Jan 31, 2024 |